Menu
Biolligence offers population-based human data tailored to enable precision clinical trials. By integrating diverse health insights, it enhances trial accuracy and supports personalized medicine, advancing efficient and targeted therapeutic development.
BioTox is an innovative AI platform from Biolligence that helps pharmaceutical companies identify potential safety risks early, saving time and reducing development costs. By offering detailed insights, BioTox supports better decision-making, ultimately bringing safer, more effective drugs to market faster.
Our platform generates human-relevant, population-diverse data to predict drug responses across various genetic and demographic backgrounds. This approach enhances the accuracy of toxicity predictions, supporting safer and more effective clinical trial designs.
Leveraging sophisticated AI algorithms trained on millions of data points, Biolligence provides deep, explainable insights into mechanisms of toxicity.
